Pyramid Schemes and Pipeline Dreams: Adapting to a Tiered Regulatory System for New Drugs

FDA's new drug safety authorities suggest that the focus of drug development and lifecycle management strategies need to change. It is no longer a question of what it takes to get approval from FDA, but rather what kind of approval you can get.